Cancer Epidemiology, July 22, 2014. Our brief commentary in Cancer Epidemiology in July 2014 points out that a lack of racial and ethnic diversity in clinical trials submitted to the FDA may exacerbate the growing racial disparity in breast cancer survival, as well as other racial disparities in survival.
Read More »Our Research & Training
We conduct research on the safety and effectiveness of medical products such as Alzheimer’s drugs, cancer drugs, and medical implants and devices used for a wide range of health problems, such as heart disease and joint replacement. In addition to the free information on this website and on www.stopcancerfund.org, we also publish articles in major medical journals and health policy journals.
These are the summaries of studies we’ve done, and here are the articles we’ve published in medical journals and health policy journals in the last few years.
Are you a reporter or medical writer interested in our free Health Research Training Workshop? Learn more here.
NCHR Comment on Silicone Wristbands as Personal Passive Samplers
Environmental Science and Technology, July 10, 2014. Silicone bracelets may, as “chemical exposure monitors,” act as personal data-gathering devices to document an individual’s chemical exposures.
Read More »Regulatory Reticence and Medical Devices
The Milbank Quarterly, March 6, 2014. Our analysis of the recent history of device regulation in the United States, however, leads to a less optimistic conclusion: that these changes in regulatory policy fail to adequately address the central shortcoming in the regulation of medical devices in the United States and Europe.
Read More »Comment on ‘Statement on Combined Hormonal Contraceptives Containing Third- or Fourth-Generation Progestogens or Cyproterone Acetate, and the Associated Risk of Thromboembolism’
Journal of Family Planning and Reproductive Health Care, July 8, 2013. Despite the increased interest in evidence-based medicine, many medical guidelines and statements of medical professionals are based primarily on opinion rather than scientific facts. The ‘Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism’ raises such concerns.
Read More »Hip Implant Failure for Men and Women: What and When We Need to Know
JAMA Internal Medicine, February 18, 2013. Total hip replacement is a popular procedure that is increasing as baby boomers age. A new study by Inacio et al in this issue of JAMA Internal Medicine reports that most hip implant patients are women, and that their risk of implant failure is higher than men’s.
Read More »